Početna › Dijabetes tipa 2 › Mississippi
Kliničke studije za Dijabetes tipa 2 u državi Mississippi
9 studija za Dijabetes tipa 2 traži sudionike na lokacijama u državi Mississippi.
Gradovi u državi Mississippi
Službeni tekst studije (engleski)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Olive Branch Family Medical Center, Olive Branch
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Prime Health and Wellness, Fayette
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Olive Branch Family Medical Center, Olive Branch
- SKY Clinical Research Network Group - Ridgeland, Ridgeland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07754461A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fayette
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Gulfport
- AURORA-2 Clinical Site, Jackson
- AURORA-2 Clinical Site, Olive Branch
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Sky Integrative Medical Center, Ridgeland
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Olive Branch Family Medical Center, Olive Branch
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Ridgeland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662109A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of Mississippi Medical Center, Jackson
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06739122Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.